The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin

Biomaterials

Volumn 32, Issue 8, 2011, Pages 2059-2069

  Singh, Shivani ^a   Wu, Benjamin M ^a,b   Dunn, James C Y ^a,b  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Cross linking; Heparin; Polycaprolactone; Scaffold; Surface modification

Indexed keywords

ANGIOGENESIS; CROSSLINKING REACTION; DOSE-DEPENDENT; HEPARIN; IN-VIVO; INDIVIDUAL COMPONENTS; POLYCAPROLACTONE SCAFFOLDS; SCAFFOLD THICKNESS; SMOOTH MUSCLE CELLS; SUBMICRON; SURFACE MODIFICATION; THICK LAYERS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOACTIVITY; BLOOD VESSELS; PHOSPHORYLATION; POLYCAPROLACTONE; POLYSACCHARIDES;

SCAFFOLDS;

HEPARIN; MOLECULAR SCAFFOLD; POLYCAPROLACTONE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; IMPLANTATION; IN VIVO STUDY; MOUSE; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER;

ANIMALS; BIOCOMPATIBLE MATERIALS; CROSS-LINKING REAGENTS; FIBRINOLYTIC AGENTS; HEPARIN; IMPLANTS, EXPERIMENTAL; MATERIALS TESTING; MICE; MICE, INBRED NOD; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; POLYESTERS; SURFACE PROPERTIES; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 78651417650     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.038     Document Type: Article

References (24)

1. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19(11):1029-1034.
2. Lee K.Y., Peters M.C., Mooney D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release 2003, 87(1-3):49-56.
3. Sun G., Shen Y., Kusuma S., Fox-Talbot K., J Steenbergen C., Gerecht S. Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials 2011, 32(1):95-106.
4. Freeman I., Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009, 30(11):2122-2131.
5. Elcin A.E., Elcin Y.M. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. Tissue Eng 2006, 12(4):959-968.
6. Chiu L.L., Radisic M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010, 31(2):226-241.
7. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380(6573):435-439.
8. Ferrara N., Chen H., Davis-Smyth T., Gerber H.P., Nguyen T.N., Peers D., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998, 4(3):336-340.
9. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 2003, 17(15):2260-2262.
10. Phelps E.A., Landázuri N., Thulé P.M., Taylor W.R., García A.J. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci USA 2010, 107(8):3323-3328.
11. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999, 5(5):495-502.
12. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003, 161(6):1163-1177.
13. Ruhrberg C., Gerhardt H., Golding M., Watson R., Ioannidou S., Fujisawa H., et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002, 16(20):2684-2698.
14. Brandner B., Kurkela R., Vihko P., Kungl A.J. Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding. Biochem Biophys Res Commun 2006, 340(3):836-839.
15. Nillesen S.T., Geutjes P.J., Wismans R., Schalkwijk J., Daamen W.F., van Kuppevelt T.H. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2007, 28(6):1123-1131.
16. Steffens G.C., Yao C., Prével P., Markowicz M., Schenck P., Noah E.M., et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 2004, 10(9-10):1502-1509.
17. Yao C., Markowicz M., Pallua N., Noah E.M., Steffens G. The effect of cross-linking of collagen matrices on their angiogenic capability. Biomaterials 2008, 29(1):66-74.
18. Jeon O., Song S.J., Kang S., Putnam A.J., Kim B. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 2007, 28(17):2763-2771.
19. Ohta M., Suzuki Y., Chou H., Ishikawa N., Suzuki S., Tanihara M., et al. Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve. J Biomed Mater Res A 2004, 71(4):661-668.
20. Jiang T., Khan Y., Nair L.S., Abdel-Fattah W.I., Laurencin C.T. Functionalization of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds via surface heparinization for bone tissue engineering. J Biomed Mater Res A 2010, 93(3):1193-1208.
21. Im G., Lee J.H. Repair of osteochondral defects with adipose stem cells and a dual growth factor-releasing scaffold in rabbits. J Biomed Mater Res Part B Appl Biomater 2010, 92(2):552-560.
22. Kim M., Lee J.Y., Jones C.N., Revzin A., Tae G. Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes. Biomaterials 2010, 31(13):3596-3603.
23. Ho Y.C., Mi F.L., Sung H.W., Kuo P.L. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. Int J Pharm 2009, 376(1-2):69-75.
24. Davies N., Dobner S., Bezuidenhout D., Schmidt C., Beck M., Zisch A.H., et al. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 2008, 29(26):3531-3538.